In-vitro Activity of RP 59500, a New Sernisynthetic Injectable Pristinamycin against Staphylococci
- 30 April 1996
- journal article
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 283 (4) , 497-501
- https://doi.org/10.1016/s0934-8840(96)80127-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1995
- Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalisNCTC 12201 toStaphylococcus aureusFEMS Microbiology Letters, 1992
- The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combinationJournal of Antimicrobial Chemotherapy, 1992
- Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococi with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibioticsJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studiesJournal of Antimicrobial Chemotherapy, 1992
- Comparative in-vitro activity of RP 59500 against clinical bacterial isolatesJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1992
- Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compoundsJournal of Antimicrobial Chemotherapy, 1992
- In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1991
- WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1989